The Economic Times daily newspaper is available online now.

    Policybazaar subsidiary invests $7.5 million in Visit Health

    Synopsis

    Visit has already raised a seed round of $1.4 million from investors such as MapmyIndia, Snapdeal cofounders Kunal Bahl and Rohit Bansal, and Hetero Drugs Director Murali Krishna.

    Online pharmaciesETtech
    Illustration: Rahul Awasthi
    Health tech startup Docprime, a subsidiary of Policybazaar parent PB Fintech, said it has invested $7.5 million in AI-driven telehealth and wellness platform Visit Health as part of its Series A funding round.

    PB Fintech said the investment is in line with its goal of enhancing service capabilities in the health and wellness space.

    Elevate Your Tech Prowess with High-Value Skill Courses

    Offering CollegeCourseWebsite
    MIT xPROMIT Technology Leadership and InnovationVisit
    IIT DelhiCertificate Programme in Data Science & Machine LearningVisit
    Indian School of BusinessProfessional Certificate in Product ManagementVisit
    Visit has already raised a seed round of $1.4 million from investors such as MapmyIndia, Snapdeal cofounders Kunal Bahl and Rohit Bansal, and Hetero Drugs Director Murali Krishna.

    Founded in 2016 by Anurag Prasad, Visit Health enables corporate employees to manage their healthcare needs on smartphones. The platform empowers enterprises to enhance the healthcare experience and optimise medical costs for all their employees.

    “Our goal with this investment is to back Visit Health in their vision to build a strong digital health ecosystem - with outstanding customer service and new ways to help customers navigate a healthcare system,” said Yashish Dahiya, chairman and CEO, PB Fintech.

    Docprime is into supplying, facilitating, and consulting services and acting as an agent, facilitator, representative in healthcare, wellness and personal care products.

    “Our product offering is backed by health insurers and the large cashless network stitched by us. With this investment, we plan to grow our platform and network capabilities and expand our teams across technology, sales, and network functions,” said Anurag Prasad, CEO, Visit.

    Health tech and tele-medicine platforms have got a further fillip in the business due to the pandemic where people preferred reaching out to healthcare providers from the comfort of their homes. In the recent past, health tech companies such as ConnectedH, HealthPlix, mHealth have received early stage funding from risk investors.
    The Economic Times

    Stories you might be interested in